-
Something wrong with this record ?
Diplacone and mimulone ameliorate dextran sulfate sodium-induced colitis in rats
Z. Vochyánová, L. Bartošová, V. Bujdáková, P. Fictum, R. Husník, P. Suchý, K. Šmejkal, J. Hošek,
Language English Country Netherlands
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Cyclooxygenase 2 metabolism MeSH
- Flavanones pharmacology MeSH
- Catalase metabolism MeSH
- Colitis chemically induced drug therapy MeSH
- Colon drug effects physiopathology MeSH
- Matrix Metalloproteinase 2 metabolism MeSH
- Disease Models, Animal MeSH
- Molecular Structure MeSH
- Rats, Wistar MeSH
- Dextran Sulfate adverse effects MeSH
- Superoxide Dismutase metabolism MeSH
- Animals MeSH
- Check Tag
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Diplacone (1) and mimulone (2), two geranylated flavanones, have previously shown anti-inflammatory and antiradical activity in vitro. The present study aimed to evaluate their activity in vivo on a model of colitis induced in Wistar rats by an oral administration of dextran sulfate sodium (DSS). Diplacone (1) and mimulone (2) were administered at a bolus dose of 25mg/kg by gastric gavage 48 and 24h prior to the induction of colitis by DSS and every 24h on the following days of the experiment. The effect of the treatment was assessed by monitoring the disease activity index (DAI), histopathological examination, evaluation of the weight and length of the colon and by analysis of the levels and activities of cyclooxygenase-2 (COX-2), matrix metalloproteinase-2 (MMP2), superoxide dismutase-2 (SOD2), and catalase (CAT) in the inflamed tissue. Administration of the test compounds prior and after induction of colitis ameliorated the symptoms of colitis (diarrhea, presence of the blood in the stool) and delayed their onset. The ability of compounds 1 and 2 to reduce the levels of COX-2 and to increase the ratio of pro-MMP2/MMP2 activity correlates with the values of the DAI. The lowering of the levels of the antioxidant enzymes SOD2 and CAT reflects the ability of the test compounds to scavenge reactive oxygen species.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15022849
- 003
- CZ-PrNML
- 005
- 20150728110022.0
- 007
- ta
- 008
- 150709s2015 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.fitote.2015.01.012 $2 doi
- 035 __
- $a (PubMed)25623260
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Vochyánová, Zora $u Department of Natural Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, 612 42 Brno, Czech Republic.
- 245 10
- $a Diplacone and mimulone ameliorate dextran sulfate sodium-induced colitis in rats / $c Z. Vochyánová, L. Bartošová, V. Bujdáková, P. Fictum, R. Husník, P. Suchý, K. Šmejkal, J. Hošek,
- 520 9_
- $a Diplacone (1) and mimulone (2), two geranylated flavanones, have previously shown anti-inflammatory and antiradical activity in vitro. The present study aimed to evaluate their activity in vivo on a model of colitis induced in Wistar rats by an oral administration of dextran sulfate sodium (DSS). Diplacone (1) and mimulone (2) were administered at a bolus dose of 25mg/kg by gastric gavage 48 and 24h prior to the induction of colitis by DSS and every 24h on the following days of the experiment. The effect of the treatment was assessed by monitoring the disease activity index (DAI), histopathological examination, evaluation of the weight and length of the colon and by analysis of the levels and activities of cyclooxygenase-2 (COX-2), matrix metalloproteinase-2 (MMP2), superoxide dismutase-2 (SOD2), and catalase (CAT) in the inflamed tissue. Administration of the test compounds prior and after induction of colitis ameliorated the symptoms of colitis (diarrhea, presence of the blood in the stool) and delayed their onset. The ability of compounds 1 and 2 to reduce the levels of COX-2 and to increase the ratio of pro-MMP2/MMP2 activity correlates with the values of the DAI. The lowering of the levels of the antioxidant enzymes SOD2 and CAT reflects the ability of the test compounds to scavenge reactive oxygen species.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a katalasa $x metabolismus $7 D002374
- 650 _2
- $a kolitida $x chemicky indukované $x farmakoterapie $7 D003092
- 650 _2
- $a kolon $x účinky léků $x patofyziologie $7 D003106
- 650 _2
- $a cyklooxygenasa 2 $x metabolismus $7 D051546
- 650 _2
- $a síran dextranu $x škodlivé účinky $7 D016264
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a flavanony $x farmakologie $7 D044950
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a matrixová metaloproteinasa 2 $x metabolismus $7 D020778
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a superoxiddismutasa $x metabolismus $7 D013482
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bartošová, Ladislava $u Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, 612 42 Brno, Czech Republic.
- 700 1_
- $a Bujdáková, Veronika $u Department of Natural Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, 612 42 Brno, Czech Republic.
- 700 1_
- $a Fictum, Petr $u Department of Pathological Morphology and Parasitology, Faculty of Veterinary Medicine, University of Veterinary and Pharmaceutical Sciences Brno, 612 42 Brno, Czech Republic.
- 700 1_
- $a Husník, Roman $u Department of Veterinary Clinical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70808, USA; International Clinical Research Center (ICRC), St. Anne's University Hospital Brno, Pekařská 53, 656 91 Brno, Czech Republic.
- 700 1_
- $a Suchý, Pavel $u Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, 612 42 Brno, Czech Republic.
- 700 1_
- $a Šmejkal, Karel $u Department of Natural Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, 612 42 Brno, Czech Republic.
- 700 1_
- $a Hošek, Jan $u Department of Molecular Biology and Pharmaceutical Biotechnology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, 612 42 Brno, Czech Republic. Electronic address: hosekj@vfu.cz.
- 773 0_
- $w MED00001802 $t Fitoterapia $x 1873-6971 $g Roč. 101, č. - (2015), s. 201-7
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25623260 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150709 $b ABA008
- 991 __
- $a 20150728110107 $b ABA008
- 999 __
- $a ok $b bmc $g 1083188 $s 905842
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 101 $c - $d 201-7 $i 1873-6971 $m Fitoterapia $n Fitoterapia (Milano) $x MED00001802
- LZP __
- $a Pubmed-20150709
